Ovarian Cancer: Our Clinical Trials

Here you can find a continually updated listing of Memorial Sloan-Kettering’s clinical trials for ovarian cancer. To learn more about a study, choose from the list below.

Showing 18 trials
Titlesort icon Investigator
A Multicenter Trial Evaluating Computed Tomography and Serum CA-125 for the Management of Newly Diagnosed Ovarian Cancer
[Protocol 01-048] 		Chi, Dennis, MD
A Phase I Study of ABT-888 in Combination with Carboplatin and Gemcitabine in Patients with Advanced Solid Tumors
[Protocol 09-154] 		Bell-McGuinn, Katherine, MD, PhD
A Phase I Study of Carboplatin/Paclitaxel/Bevacizumab and ABT-888 in Patients with Previously Untreated Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
[Protocol 09-106] 		Bell-McGuinn, Katherine, MD, PhD
A Phase I Study of WT1-Specific T Cells for the Treatment of Patients with Advanced Ovarian, Primary Peritoneal, and Fallopian Tube Cancers
[Protocol 06-155] 		O'Cearbhaill, Roisin, MB BCh BAO
A Phase I Trial of a New Vaccine (Globo-H-GM2-sTn-TF-Tn) for Patients with Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer in First Remission
[Protocol 09-184] 		Sabbatini, Paul, MD
A Phase I/II Study of CDX-1401 in Patients with Cancers Known to Express NY-ESO-1
[Protocol 09-165] 		Keohan, Mary, MD
A Phase II Study of Bevacizumab with or without Everolimus to Treat Recurrent or Persistent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
[Protocol 10-168] 		Tew, William, MD
A Phase II Study of the Biologic Effect of Levonorgestrel on the Ovarian Epithelium in Women at High Risk for Ovarian Cancer
[Protocol 08-150] 		Kauff, Noah, MD
A Phase II Study of TRC105 to Treat Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
[Protocol 11-165] 		Makker, Vicky, MD
A Phase III Study of Carboplatin and Paclitaxel Alone or with Bevacizumab Followed by Bevacizumab and Secondary Cytoreductive Surgery in Platinum-Sensitive, Recurrent Ovarian, Primary Peritoneal, and Fallopian Tube Cancer
[Protocol 08-074] 		Leitao, Mario, MD
A Phase III Study of Paclitaxel Every Three Weeks Versus Dose-Dense Weekly Paclitaxel in Combination with Carboplatin, with or without Bevacizumab, to Treat Stage III or IV Ovarian, Peritoneal, or Fallopian Tube Cancer
[Protocol 11-008] 		Leitao, Mario, MD
A Pilot Study of a Polyvalent Vaccine Plus Bevacizumab in Patients with Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in Second or Greater Remission
[Protocol 10-099] 		Sabbatini, Paul, MD
A Pilot Study Surveying Female Cancer Patients' Preference for Sexual Health Interventions
[Protocol 10-034] 		Carter, Jeanne, PhD
A Prospective Study of Quality of Life in Patients Undergoing Pelvic Exenteration
[Protocol 05-001] 		Chi, Dennis, MD
Clinical Significance of Germline BRCA Mutations
[Protocol 96-051] 		Offit, Kenneth, MD
Electronic Patient-Reported Outcomes from Home in Patients Recovering from Major Gynecologic Cancer Surgery: Measuring Symptoms and Quality of Life
[Protocol 08-155] 		Chi, Dennis, MD
Geriatric Assessment and Nursing Telephone Intervention in Elderly Women with Ovarian Cancer
[Protocol 11-164] 		Tew, William, MD
Standard Infusion Carboplatin versus Prophylactic Extended Infusion Carboplatin in the Treatment of Patients with Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
[Protocol 10-184] 		O'Cearbhaill, Roisin, MB BCh BAO
Related Topics
Recommended Links

Clinical Trials

Clinical trials can offer you access to a new, experimental treatment before it is available to most patients. Joining a clinical trial is also a way to make a valuable contribution toward the fight against cancer.